Chemical approaches to development of mitochondrial-targeted Hsp90 inhibitor in anti-cancer therapeutics: Mechanism and structure change of mitochondrial Hsp90

被引：0
|
作者：
Hu, Sung
Yoon, Nam Gu
Kang, Byoung Heon
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1492
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical Development
    Soga, Shiro
    Akinaga, Shiro
    Shiotsu, Yukimasa
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (03) : 366 - 376
  • [32] Nitration of Hsp90 on Tyrosine 33 Regulates Mitochondrial Metabolism
    Franco, Maria C.
    Ricart, Karina C.
    Gonzalez, Analia S.
    Dennys, Cassandra N.
    Nelson, Pascal A.
    Janes, Michael S.
    Mehl, Ryan A.
    Landar, Aimee
    Estevez, Alvaro G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (31) : 19055 - 19066
  • [33] Structure, function, and mechanism of the Hsp90 molecular chaperone
    Pearl, LH
    Prodromou, C
    [J]. PROTEIN FOLDING IN THE CELL, 2002, 59 : 157 - 186
  • [34] Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor
    Hayat, Umar
    Elliott, Gary T.
    Olszanski, Anthony J.
    Altieri, Dario C.
    [J]. CANCER BIOLOGY & THERAPY, 2022, 23 (01) : 117 - 126
  • [35] Structure and mechanism of the Hsp90 molecular chaperone machinery
    Pearl, Laurence H.
    Prodromou, Chrisostomos
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 : 271 - 294
  • [36] Development of Hsp90 paralog specific inhibitors with mitochondrial drug delivery system
    Kang, Byoung Heon
    [J]. CANCER RESEARCH, 2015, 75
  • [37] New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
    Li, Yanyan
    Zhang, Tao
    Schwartz, Steven J.
    Sun, Duxin
    [J]. DRUG RESISTANCE UPDATES, 2009, 12 (1-2) : 17 - 27
  • [38] Hsp90 Inhibitor-Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
    Ha, Kyungsoo
    Fiskus, Warren
    Rao, Rekha
    Balusu, Ramesh
    Venkannagari, Sreedhar
    Nalabothula, Narasimha Rao
    Bhalla, Kapil N.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10 (07) : 1194 - 1206
  • [39] [11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics
    Cools, Romy
    Narykina, Valeria
    Vermeulen, Koen
    Bormans, Guy
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S18 - S18
  • [40] Hsp90 inhibition accelerates cell lysis -: Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide- and Hsp90-dependent events
    Sreedhar, AS
    Mihály, K
    Pató, B
    Schnaider, T
    Steták, A
    Kis-Petik, K
    Fidy, J
    Simonics, T
    Maráz, A
    Csermely, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) : 35231 - 35240
12345